Differences in lesion characteristics and patient background associated with the medium-term clinical outcomes of bare-metal and first-, second- and third-generation drug-eluting stents.
Masayuki Nakamura; Amane Ike; Yuta Kato; Makito Futami; Takashi Kuwano; Makoto Sugihara; Atsushi Iwata; Akira Kawamura; Yasunori Suematsu; Shin-Ichiro Miura
Heart and vessels, Feb. 2021, 36(2):211 - 222

A Strict Target for Low-Density Lipoprotein Cholesterol May not Be Necessary for Secondary Prevention of Cardiovascular Disease in All Elderly Patients With Dyslipidemia.
Shin-Ichiro Miura; Yousuke Katsuda; Makoto Sugihara; Amane Ike; Hiroaki Nishikawa; Akira Kawamura
Cardiology research, Dec. 2020, 11(6):366 - 369

Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide.
Yasunori Suematsu; Emi Kawachi; Yoshiaki Idemoto; Yoshino Matsuo; Takashi Kuwano; Ken Kitajima; Satoshi Imaizumi; Akira Kawamura; Keijiro Saku; Yoshinari Uehara; Shin-Ichiro Miura
International journal of cardiology, 15 Dec. 2019, 297:111 - 117

Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry (vol 33, pg 102, 2018)
Shiiba, Michiyo; Zhang, Bo; Miura, Shin-ichiro; Ike, Amane; Nose, Daisuke; Kuwano, Takashi; Imaizumi, Satoshi; Sugihara, Makoto; Iwata, Atushi; Nishikawa, Hiroaki; Kawamura, Akira; Shirai, Kazuyuki; Yasunaga, Shin'ichiro; Saku, Keijiro
Heart and Vessels, 2019, 34(1):197 - 198

The Current Conditions and Lifestyles of Obese University Students.
Natsumi Morito; Yasunori Suematsu; Rie Koyoshi; Yuhei Shiga; Takashi Kuwano; Atsushi Iwata; Kanta Fujimi; Akira Kawamura; Shin-Ichiro Miura
Journal of clinical medicine research, Mar. 2018, 10(3):240 - 246

Sex difference between target levels of cholesterol-related parameters and post-PCI long-term clinical outcomes: From the FU-Registry.
Yuta Matsuoka; Amane Ike; Masahiro Ogawa; Kouki Gondo; Kazuyuki Shirai; Makoto Sugihara; Daisuke Nose; Hiroaki Nishikawa; Atsushi Iwata; Akira Kawamura; Ken Mori; Bo Zhang; Shin'ichiro Yasunaga; Shin-Ichiro Miura; Keijiro Saku
Journal of cardiology, Mar. 2018, 71(3):259 - 267

Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry.
Michiyo Shiiba; Bo Zhang; Shin-Ichiro Miura; Amane Ike; Daisuke Nose; Takashi Kuwano; Satoshi Imaizumi; Makoto Sugihara; Atushi Iwata; Hiroaki Nishikawa; Akira Kawamura; Kazuyuki Shirai; Shin'ichiro Yasunaga; Keijiro Saku
Heart and vessels, Feb. 2018, 33(2):102 - 112

Associations between microalbuminuria and parameters of flow-mediated vasodilatation obtained by continuous measurement approaches.
Rie Koyoshi; Yuka Hitaka-Yoshimine; Yuhei Shiga; Takashi Kuwano; Makoto Sugihara; Amane Ike; Atsushi Iwata; Hideto Sako; Natsumi Morito; Akira Kawamura; Shin-Ichiro Miura
Clinical and experimental hypertension (New York, N.Y. : 1993), 2018, 40(8):715 - 720

Safety of Landiolol Hydrochloride as a Premedication for Producing an Appropriate Heart Rate for Multidetector-Row Computed Tomography Coronary Angiography.
Rie Koyoshi; Yuhei Shiga; Yoshiaki Idemoto; Yoko Ueda; Kohei Tashiro; Takashi Kuwano; Ken Kitajima; Kanta Fujimi; Akira Kawamura; Masahiro Ogawa; Shin-Ichiro Miura
Journal of clinical medicine research, Jan. 2018, 10(1):22 - 26

Is a bare-metal stent still useful for improving the outcome of percutaneous coronary intervention? From the FU-Registry.
Kouki Gondo; Amane Ike; Masahiro Ogawa; Kazuyuki Shirai; Makoto Sugihara; Hiroaki Nishikawa; Atsushi Iwata; Akira Kawamura; Ken Mori; Bo Zhang; Shin'ichiro Miura; Shin'ichiro Yasunaga; Keijiro Saku
Journal of cardiology, Apr. 2017, 69(4):652 - 659

Associations between different types of hypoglycemic agents and the clinical outcome of percutaneous coronary intervention in diabetic patients-From the FU-Registry.
Amane Ike; Kazuyuki Shirai; Hiroaki Nishikawa; Atushi Iwata; Eiji Yahiro; Makoto Sugihara; Akira Kawamura; Yoshinari Uehara; Bo Zhang; Masahiro Ogawa; Ken Mori; Shin-ichiro Miura; Keijiro Saku
Journal of cardiology, May 2015, 65(5):390 - 6

Associations between lipid profiles and MACE in hemodialysis patients with percutaneous coronary intervention: from the FU-Registry.
Itsuki Nagata; Amane Ike; Hiroaki Nishikawa; Bo Zhang; Makoto Sugihara; Ken Mori; Atsushi Iwata; Akira Kawamura; Kazuyuki Shirai; Yoshinari Uehara; Masahiro Ogawa; Shin-Ichiro Miura; Keijiro Saku
Journal of cardiology, Feb. 2015, 65(2):105 - 11

Azelnidipine, Not Amlodipine, Induces Secretion of Vascular Endothelial Growth Factor From Smooth Muscle Cells and Promotes Endothelial Tube Formation.
Akira Kawamura; Shin-Ichiro Miura; Yoshino Matsuo; Hiroyuki Tanigawa; Keijiro Saku
Cardiology research, Oct. 2014, 5(5):145 - 150

Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-Registry.
Makoto Sugihara; Shin-ichiro Miura; Hiroaki Nishikawa; Amane Ike; Ken Mori; Atsushi Iwata; Akira Kawamura; Keijiro Saku
Journal of cardiology, Feb. 2013, 61(2):117 - 21

Comparison of the efficacies of irbesartan and olmesartan after successful coronary stent implantation.
Joji Morii; Shin-ichiro Miura; Amane Ike; Yuhei Shiga; Makoto Sugihara; Atsushi Iwata; Akira Kawamura; Hiroaki Nishikawa; Keijiro Saku
Internal medicine (Tokyo, Japan), 2013, 52(7):713 - 9

Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin.
Atsushi Iwata; Shin-Ichiro Miura; Tohru Tanaka; Amane Ike; Makoto Sugihara; Hiroaki Nishikawa; Akira Kawamura; Keijiro Saku
Coronary artery disease, Aug. 2012, 23(5):315 - 21

Comparison of the efficacy and safety of statin and statin/ezetimibe therapy after coronary stent implantation in patients with stable angina.
Tadaaki Arimura; Shin-ichiro Miura; Amane Ike; Makoto Sugihara; Atsushi Iwata; Hiroaki Nishikawa; Akira Kawamura; Keijiro Saku
Journal of cardiology, Aug. 2012, 60(2):111 - 8

[Series: clinical study from Japan and its reflections; impact of glycemic control on the clinical outcome in diabetic patients with percutaneous coronary intervention:--from the FU-registry--(UMIN registration no. 000005679)].
Amane Ike; Kazuyuki Shirai; Hiroaki Nishikawa; Bo Zhang; Akira Kawamura; Atsushi Iwata; Ken Mori; Masahiro Ogawa; Shin-Ichiro Miura; Keita Noda; Keijiro Saku
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 10 Feb. 2012, 101(2):504 - 11

日本発臨床研究の紹介と反省点を語る 経皮的冠動脈形成術施行時の、糖尿病患者に対する血糖コントロールの影響 FU-Registryからの解析(UMIN Registration No.000005679)(Impact of Glycemic Control on the Clinical Outcome in Diabetic Patients With Percutaneous Coronary Intervention : from the FU-Registry (UMIN Registration No.000005679))
池 周而; 白井 和之; 西川 宏明; 張 波; 河村 彰; 岩田 敦; 森 憲; 小川 正浩; 三浦 伸一郎; 野田 慶太; 朔 啓二郎
日本内科学会雑誌, Feb. 2012, 101(2):504 - 511

Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina.
Takahiro Mito; Shin-Ichiro Miura; Atsushi Iwata; Joji Morii; Makoto Sugihara; Amane Ike; Ken Mori; Akira Kawamura; Hiroaki Nishikawa; Bo Zhang; Keijiro Saku
Coronary artery disease, Nov. 2011, 22(7):451 - 7

Significance of pigment epithelium-derived factor levels with angiotensin II type 1 receptor blockers in patients with successful coronary stent implantation.
Makoto Sugihara; Shin-Ichiro Miura; Yosuke Takamiya; Yoshihiro Kiya; Tadaaki Arimura; Atsushi Iwata; Akira Kawamura; Hiroaki Nishikawa; Sho-Ichi Yamagishi; Keijiro Saku
Journal of the renin-angiotensin-aldosterone system : JRAAS, Sep. 2011, 12(3):320 - 5

Angiographic late lumen loss at the site of overlap of multiple Cypher™ sirolimus-eluting stents: ALSOCE study.
Yosuke Takamiya; Shin-ichiro Miura; Yoshihiro Tsuchiya; Yusuke Fukuda; Bo Zhang; Takashi Kuwano; Amane Ike; Daizaburo Yanagi; Kazumitsu Kubota; Ken Mori; Atsushi Iwata; Hiroaki Nishikawa; Akira Kawamura; Nathan Miller; Kunihiro Matsuo; Kazuyuki Shirai; Keijiro Saku
Journal of cardiology, Mar. 2011, 57(2):187 - 93

Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an old molecule.
Takashi Kuwano; Shin-Ichiro Miura; Kazuyuki Shirai; Amane Ike; Ken Mori; Tomohiko Shimizu; Bo Zhang; Atsushi Iwata; Hiroaki Nishikawa; Akira Kawamura; Keijiro Saku
Journal of atherosclerosis and thrombosis, 2011, 18(7):574 - 83

Significance of serum high-density lipoprotein cholesterol levels for diagnosis of coronary stenosis as determined by MDCT in patients with suspected coronary artery disease.
Yuhei Shiga; Shin-ichiro Miura; Ryoko Mitsutake; Akira Kawamura; Yoshinari Uehara; Keijiro Saku
Journal of atherosclerosis and thrombosis, 31 Aug. 2010, 17(8):870 - 8

Homocysteine-induced oxidative stress upregulates chymase in mouse mastocytoma cells.
Kanta Fujimi; Yoshinari Uehara; Satomi Abe; Akira Kawamura; Sankar Devarajan; Shin-Ichiro Miura; Keijiro Saku; Hidenori Urata
Hypertension research : official journal of the Japanese Society of Hypertension, Feb. 2010, 33(2):149 - 54

Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation.
Makoto Sugihara; Shin-Ichiro Miura; Yosuke Takamiya; Yoshihiro Kiya; Tadaaki Arimura; Atsushi Iwata; Akira Kawamura; Hiroaki Nishikawa; Yoshinari Uehara; Keijiro Saku
Hypertension research : official journal of the Japanese Society of Hypertension, Jul. 2009, 32(7):625 - 30

Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease.
Yosuke Takamiya; Shin-Ichiro Miura; Akira Kawamura; Hiroyuki Tanigawa; Bo Zhang; Atsushi Iwata; Hiroaki Nishikawa; Kunihiro Matsuo; Kazuyuki Shirai; Keijiro Saku
Coronary artery disease, Jun. 2009, 20(4):288 - 94

Association between cardiac function and metabolic factors including adiponectin in patients with acute myocardial infarction.
Kumi Kimura; Shin-ichiro Miura; Atsushi Iwata; Makoto Sugihara; Tadaaki Arimura; Hiroaki Nishikawa; Akira Kawamura; Keijiro Saku
Journal of cardiology, Feb. 2009, 53(1):65 - 71

Significance of urinary liver-fatty acid-binding protein in cardiac catheterization in patients with coronary artery disease.
Yusuke Fukuda; Shin-ichiro Miura; Bo Zhang; Atsushi Iwata; Akira Kawamura; Hiroaki Nishikawa; Kazuyuki Shirai; Keijiro Saku
Internal medicine (Tokyo, Japan), 2009, 48(19):1731 - 7

Are metabolic factors associated with coronary artery stenosis on MDCT?
Ryoko Mitsutake; Shin-ichiro Miura; Akira Kawamura; Keijiro Saku
Circulation journal : official journal of the Japanese Circulation Society, Jan. 2009, 73(1):132 - 8

Associations between metabolic factors and coronary plaque growth or arterial remodeling as assessed by intravascular ultrasound in patients with stable angina.
Atsushi Iwata; Shin-Ichiro Miura; Ken Mori; Akira Kawamura; Hiroaki Nishikawa; Keijiro Saku
Hypertension research : official journal of the Japanese Society of Hypertension, Oct. 2008, 31(10):1879 - 86

HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production.
Markus Tölle; Alicja Pawlak; Miriam Schuchardt; Akira Kawamura; Uwe J Tietge; Stefan Lorkowski; Petra Keul; Gerd Assmann; Jerold Chun; Bodo Levkau; Markus van der Giet; Jerzy-Roch Nofer
Arteriosclerosis, thrombosis, and vascular biology, Aug. 2008, 28(8):1542 - 8

Results of provisional stenting with a Sirolimus-eluting stent for bifurcation lesion: multicenter study in Japan.
Daizaburo Yanagi; Kazuyuki Shirai; Yosuke Takamiya; Yusuke Fukuda; Takashi Kuwano; Amane Ike; Ken Mori; Kazumitsu Kubota; Atsushi Iwata; Kanta Fujimi; Akira Kawamura; Hiroaki Nishikawa; Nathan Miller; Bo Zhang; Yoshihiro Tsuchiya; Hidenori Urata; Keijiro Saku
Journal of cardiology, Apr. 2008, 51(2):89 - 94

Efficacy and safety of drug-eluting stents in long-term follow-up.
Shin-Ichiro Miura; Akira Kawamura; Keijiro Saku
Internal medicine (Tokyo, Japan), 2008, 47(11):987 - 8

Changes in CCR2 chemokine receptor expression and plasma MCP-1 concentration after the implantation of bare metal stents versus sirolimus-eluting stents in patients with stable angina.
Hideto Sako; Shin-ichiro Miura; Atsushi Iwata; Hiroaki Nishikawa; Akira Kawamura; Kunihiro Matsuo; Kazuyuki Shirai; Keijiro Saku
Internal medicine (Tokyo, Japan), 2008, 47(1):7 - 13

Is chronic kidney disease associated with coronary artery stenosis or calcification as assessed by multi-detector row computed tomography?
Ryoko Mitsutake; Shin-ichiro Miura; Yuhei Shiga; Akira Kawamura; Keijiro Saku
Internal medicine (Tokyo, Japan), 2008, 47(21):1835 - 41

Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation.
Yoshino Matsuo; Shin-ichiro Miura; Akira Kawamura; Yoshinari Uehara; Kerry-Anne Rye; Keijiro Saku
Atherosclerosis, Sep. 2007, 194(1):159 - 68

Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells.
Akira Kawamura; Daniel Baitsch; Ralph Telgmann; Renata Feuerborn; Gabriele Weissen-Plenz; Claudia Hagedorn; Keijiro Saku; Stefan-Martin Brand-Herrmann; Arnold von Eckardstein; Gerd Assmann; Jerzy-Roch Nofer
Arteriosclerosis, thrombosis, and vascular biology, Jul. 2007, 27(7):1610 - 7

Clinical significance of the coronary calcification score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients.
Ryoko Mitsutake; Hideya Niimura; Shin-ichiro Miura; Bo Zhang; Atsushi Iwata; Hiroaki Nishikawa; Akira Kawamura; Koichiro Kumagai; Kazuyuki Shirai; Akira Matsunaga; Keijiro Saku
Circulation journal : official journal of the Japanese Circulation Society, Sep. 2006, 70(9):1122 - 7

Pitavastatin-induced downregulation of CCR2 and CCR5 in monocytes is associated with the arrest of cell-cycle in S phase.
Masahiro Fujino; Shin-ichiro Miura; Yoshino Matsuo; Hiroaki Tanigawa; Akira Kawamura; Keijiro Saku
Atherosclerosis, Aug. 2006, 187(2):301 - 8

Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease.
Satoshi Imaizumi; Shin-ichiro Miura; Hiroaki Nishikawa; Atsushi Iwata; Bo Zhang; Akira Kawamura; Yoshihiro Tsuchiya; Koichiro Kumagai; Kunihiro Matsuo; Keijiro Saku
Hypertension research : official journal of the Japanese Society of Hypertension, Mar. 2006, 29(3):135 - 41

Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction.
Atsushi Iwata; Shin-ichiro Miura; Kazuyuki Shirai; Akira Kawamura; Sayo Tomita; Yoshino Matsuo; Bo Zhang; Hiroaki Nishikawa; Koichiro Kumagai; Kunihiro Matsuo; Keijiro Saku
Internal medicine (Tokyo, Japan), 2006, 45(15):885 - 90

Significance of combined angiotensin II receptor blocker and carvedilol therapy in patients with congestive heart failure and arginine variant.
Atsushi Iwata; Shin-ichiro Miura; Hiroaki Nishikawa; Akira Kawamura; Yoshino Matsuo; Hideto Sako; Koichiro Kumagai; Kunihiro Matsuo; Keijiro Saku
Journal of cardiology, Jan. 2006, 47(1):1 - 7

JTT-705 blocks cell proliferation and angiogenesis through p38 kinase/p27(kip1) and Ras/p21(waf1) pathways.
Shin-Ichiro Miura; Yoshino Matsuo; Akira Kawamura; Keijiro Saku
Atherosclerosis, Oct. 2005, 182(2):267 - 75

Effect of statin on restenosis after radius stent implantation in patients with acute coronary syndrome.
Hiroaki Nishikawa; Shin-Ichiro Miura; Hideki Shimomura; Akira Kawamura; Kenichi Tsujita; Kazuyuki Shirai; Kunihiro Matsuo; Hidekazu Arai; Keijiro Saku
Journal of atherosclerosis and thrombosis, 2005, 12(6):302 - 6

Changes in the expression of leukocyte adhesion molecules throughout the acute phase of myocardial infarction.
Akira Kawamura; Shin-ichiro Miura; Takahiro Murayama; Atsushi Iwata; Hiroaki Nishikawa; Yoshino Matsuo; Yoshihiro Tsuchiya; Kunihiro Matsuo; Emiko Tsuji; Keijiro Saku
Journal of atherosclerosis and thrombosis, 2004, 11(1):29 - 34

Increased expression of monocyte CD11a and intracellular adhesion molecule-1 in patients with initial atherosclerotic coronary stenosis.
Akira Kawamura; Shin-ichiro Miura; Takahiro Murayama; Atsushi Iwata; Bo Zhang; Hiroaki Nishikawa; Yoshihiro Tsuchiya; Kunihiro Matsuo; Emiko Tsuji; Keijiro Saku
Circulation journal : official journal of the Japanese Circulation Society, Jan. 2004, 68(1):6 - 10

CXCR3 chemokine receptor-plasma IP10 interaction in patients with coronary artery disease.
Akira Kawamura; Shin-ichiro Miura; Masahiro Fujino; Hiroaki Nishikawa; Yoshino Matsuo; Hiroaki Tanigawa; Sayo Tomita; Yoshihiro Tsuchiya; Kunihiro Matsuo; Keijiro Saku
Circulation journal : official journal of the Japanese Circulation Society, Oct. 2003, 67(10):851 - 4

Ras/Raf1-dependent signal in sphingosine-1-phosphate-induced tube formation in human coronary artery endothelial cells.
Shin-ichiro Miura; Hiroyuki Tanigawa; Yoshino Matsuo; Masahiro Fujino; Akira Kawamura; Keijiro Saku
Biochemical and biophysical research communications, 11 Jul. 2003, 306(4):924 - 9

Angiotensin-converting enzyme inhibitor promotes coronary collateral circulation in patients with coronary artery disease.
Shin-Ichiro Miura; Hiroaki Nishikawa; Bo Zhang; Yoshino Matsuo; Akira Kawamura; Yoshihiro Tsuchiya; Kunihiro Matsuo; Keijiro Saku
Circulation journal : official journal of the Japanese Circulation Society, Jun. 2003, 67(6):535 - 8

High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells.
Shin-ichiro Miura; Masahiro Fujino; Yoshino Matsuo; Akira Kawamura; Hiroyuki Tanigawa; Hiroaki Nishikawa; Keijiro Saku
Arteriosclerosis, thrombosis, and vascular biology, 01 May 2003, 23(5):802 - 8

閉塞性血栓性血管炎様の病態に本態性血小板血症が複合的に関与したと思われる足趾潰瘍の１例
藤川紘志朗; 杉原充; 今泉朝樹; 池周而; 森井誠士; 志賀悠平; 北島研; 河村彰; 三浦伸一郎
心臓, 2021, 53(4):364 - 367

僧帽弁置換術16年後に弁周囲逆流により溶血性貧血を来たした一例
森田絵衣; 志賀悠平; 二見真紀人; 上田隆士; 小吉里枝; 森井誠士; 桑野孝志; 林田好生; 河村彰; 和田秀一; 三浦伸一郎
臨床と研究, 2018, 95(9):76 - 78

失神にて来院した高齢発症の閉塞性肥大型心筋症の一例
川平悠人; 上田容子; 石田紀久; 森井誠士; 杉原充; 池周而; 河村彰; 三浦伸一郎
臨床と研究, 2018, 95(4):95 - 98

アポA-I模倣ペプチドを用いた動脈硬化治療—代謝 ; 臨床分野での進歩
河村 彰; 朔 啓二郎
Annual review. 糖尿病・代謝・内分泌, 2013, :145 - 152

高HDLコレステロール血症—特集 脂質異常症 : 動脈硬化性疾患予防のために
河村 彰; 朔 啓二郎
診断と治療 = Diagnosis and treatment, Dec. 2012, 100(12):2083 - 2087

HDL Functionality Could be a Novel Marker for Predicting Restenosis after Stent Implantation
Satoshi Imaizumi; Shin-Ichiro Miura; Yosuke Takamiya; Akira Kawamura; Bo Zhang; Atsushi Iwata; Hiroaki Nishikawa; Kunihiro Matsuo; Kazuyuki Shirai; Yoshinari Uehara; Srinivasa T. Reddy; Keijiro Saku
CIRCULATION, Nov. 2012, 126(21)

Giant thrombus filling the pulmonary trunk.
Nakamura A; Uehara Y; Kawamura A; Saku K
Intern Med, 2012, 51(3):333

特集 先進循環器病治療研究会 「血管を護るための糖尿病治療戦略～インクレチン関連薬を中心に～」
朔啓二郎; 野見山崇; 仁位隆信; 岡部眞典; 白井和之; 小川正浩; 上原吉就; 河村彰; 西川宏明; 岩田敦; 佐光英人; 安田智生; 藤見幹太; 森戸夏美; 八尋英二; 光武良晃; 今泉聡
Vascular Street, 2012, 7(3):1 - 6

研究 冠攣縮性狭心症に対する長時間作用型Ca拮抗薬ニフェジピンCR錠の冠攣縮抑制効果
岩田 敦; 森 憲; 西川 宏明; 河村 彰; 朔 啓二郎
呼吸と循環, 15 Nov. 2011, 59(11):1129 - 1133

心臓カテーテル検査・PCIの必須知識と検査後の看護ポイント 合併症の知識と予防・対処
河村 彰
達人ナース：経験知の伝授誌, 2011, 32(1):47 - 51

心臓カテーテル検査・PCIの必須知識と検査後の看護ポイント 検査・治療後の患者ケアのポイント
河村彰
達人ナース: 経験知の伝授誌, 2011, 32(2):117 - 121

特集 虚血性心疾患の治療薬 脂質代謝異常改善薬
河村彰; 朔啓二郎
月間循環器 CIRCULATION, 2011, 3:53 - 63

心臓カテーテル検査・PCIの必須知識と検査後の看護ポイント(第2回) PCIを中心としたカテーテル治療
河村 彰
達人ナース: 経験知の伝授誌, Nov. 2010, 31(6):22 - 31

心臓カテーテル検査・PCIの必須知識と検査後の看護ポイント 心臓カテーテル検査の概要と検査中の看護
河村 彰
達人ナース: 経験知の伝授誌, Sep. 2010, 31(5):41 - 51

生活習慣病は本当にエビデンス通りに治療するだけで良いのだろうか？
朔啓二郎; 弘世貴久; 三浦伸一郎; 河村彰; 上原吉就
Vascular Street, 2010, 5(4):1 - 4

Acute coronary syndrome associated with essential thrombocythemia.
Kumagai N, Mitsutake R, Miura S, Kawamura A, Takamiya Y, Nishikawa H, Uehara Y, Saku K.
J Cardiol, Dec. 2009, 54(3):485 - 489

CRUSADE
河村 彰; 朔 啓二郎
DATA UPDATE 循環器系 第4版, 2009, :100 - 101

Acute myocardial infarction associated with pregnancy successfully treated with percutaneous coronary intervention.
Arimura T; Mitsutake R; Miura S; Nishikawa H; Kawamura A; Saku K
Intern Med, 2009, 48(16):1383 - 1386

【動脈硬化性疾患予防のための脂質管理】脂質異常症のやさしい理解 HDLと動脈硬化
河村 彰; 朔 啓二郎
診断と治療, Jul. 2008, 96(7):1233 - 1240

【凝固・線溶系とRAS】脂質異常症における凝固・線溶系とRAS
河村 彰; 朔 啓二郎
Angiotensin Research, Apr. 2008, 5(2):104 - 108

【慢性腎臓病(CKD)診療 透析への移行・心血管系イベント予防のために】原因疾患・合併症・患者背景に見る対応とその管理 CKDにおける脂質異常の対応と管理
河村 彰; 朔 啓二郎
治療, Apr. 2008, 90(4):1491 - 1495

急性冠症候群 長期予後を考慮した薬剤選択は？－スタチン
河村 彰; 朔 啓二郎
EBM 循環器疾患の治療2008-2009, 2008, :87 - 91

Left ventricular oozing rupture following acute myocardial infarction.
Yanagi D; Shirai K; Arimura T; Saito N; Mitsutake C; Mitsutake R; Hida S; Iwata A; Nishikawa H; Kawamura A; Miura S; Saku K
Intern Med, 2008, 47(20):1803 - 1805

内臓肥満と腹部大動脈瘤の関係
河村 彰 朔; 啓二郎
M.P. Medical Practice, 2008, 25(10):1901

【アテローム血栓症の包括的治療戦略】フィブラート系薬剤によるアテローム血栓症の予防
河村 彰; 朔 啓二郎
循環器科, Oct. 2007, 62(4):331 - 336

【脂質】脂質代謝異常と疾病 低HDLコレステロールと疾病
河村 彰; 朔 啓二郎
臨床検査, May 2007, 51(5):507 - 513

Successful intensive lipid-lowering therapy using atorvastatin stabilizes coronary artery plaque as assessed by multi-detector row computed tomography
Mitsutake R; Miura S; Okamura K; Niimura H; Kawamura A; Saku K
Intern Med, 2007, 46(12):859 - 863

【臨床各領域の動向2006-2007】循環器
河村 彰; 松本 直通; 三浦 伸一郎; 白井 和之; 熊谷 浩一郎; 朔 啓二郎
治療, Jan. 2007, 89(1):18 - 22

慢性的に心嚢液貯留を繰り返したCREST症候群の一例
桑野孝志; 三浦伸一郎; 大脇和男; 河村彰; 松尾邦浩; 福田圭介; 朔啓二郎
臨床と研究, 2003, 80:151 - 154

Deep venous thrombosis and pulmonary thromboembolism associated with a huge uterine myoma--a case report.
Nishikawa H; Ideishi M; Nishimura T; Kawamura A; Kamochi H; Tahara H; Tsuchiya Y; Shirai K; Okabe M; Arakawa K
Angiology., Feb. 2000, 51(2):161 - 166

High-Density Lipoprotein Cholesterol Handling is a Key Role for Prevention of In-Stent Restenosis.
Kawamura A; Ike A; Nishikawa H; Iwata A; Sugihara M; Matsuo K; Miura S; Saku K
第2１回日本心血管インターベンション治療学会; CVIT2012 学術集会

Apolipoprotein E interrupts NF-κB signaling by binding to IRAK-1 via LRP1 in vascular smooth muscle cells.
Kawamura A; Miura S; Uehara S; Saku K
第72回日本循環器学会総会・学術集会

Apolipoprotein E Inhibits NF-κB Activation by Binding to Interleukin Receptor Associated Kinase-1.
Kawamura A; Miura S; Uehara S; Saku K
第71回日本循環器学会総会・学術集会

Apolipoprotein E interrupts Interlrukin-1β signaling upstream of Activating Protein-1 and c-Jun in Vascular Smooth Muscle Cells.
Kawamura A; Miura S; Uehara S; Saku K
第71回日本循環器学会総会・学術集会

Increased expression of monocyte CD11a/CD18 and its ligand ICAM-1 in patients with initial atherosclerotic coronary stenosis.
Kawamura A; Miura S; Murayama T; Nishikawa H; Tomita S; Matsuo Y; Tsuchiya Y; Matsuo K; Tsuji E; Saku K
第35回日本動脈硬化学会総会

Differential expression of monocyte surface CD11a/CD18 in patients with or without coronary artery disease.
Kawamura A; Miura S; Murayama T; Nishikawa H; Matsuo Y; Tsuchiya Y; Matsuo K; Tsuji E; Saku K
The 4th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology,

Expression patterns of leukocyte adhesion molecules throughout the acute phase of myocardial infarction.
Kawamura A; Miura S; Murayama T; Nishikawa H; Matsuo Y; Tsuchiya Y; Matsuo K; Tsuji E; Saku K
The 4th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology,

Involvement of higher plasma MCP-1 concentration and lymphocyte CXCR3 chemokine receptor - plasma IP10 interaction in patients with coronary artery disease.
Kawamura A; Miura S; Fujino M; Tomita S; Nishikawa H; Matsuo Y; Tanigawa H; Tsuchiya Y; Matsuo K; Saku K
The 4th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology,

心房細動における脳心血管病予防のための降圧目標を解明する国際共同大規模臨床試験
日本学術振興会, 科学研究費助成事業, 基盤研究(B)
福岡大学
01 Apr. 2023 - 31 Mar. 2027